| Year |
Citation |
Score |
| 2022 |
Belayet JB, Beamish S, Rahaman M, Alanani S, Virdi RS, Frick DN, Rahman AFMT, Ulicki JS, Biswas S, Arnold LA, Roni MSR, Cheng EY, Steeber DA, Frick KM, Hossain MM. Development of a Novel, Small-Molecule Brain-Penetrant Histone Deacetylase Inhibitor That Enhances Spatial Memory Formation in Mice. Journal of Medicinal Chemistry. PMID 35133171 DOI: 10.1021/acs.jmedchem.1c01928 |
0.502 |
|
| 2020 |
Virdi RS, Bavisotto RV, Hopper NC, Vuksanovic N, Melkonian TR, Silvaggi NR, Frick DN. Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3. Slas Discovery : Advancing Life Sciences R & D. 2472555220960428. PMID 32981460 DOI: 10.1177/2472555220960428 |
0.726 |
|
| 2020 |
Frick DN, Virdi RS, Vuksanovic N, Dahal N, Silvaggi NR. Molecular Basis for ADP-Ribose Binding to the Mac1 Domain of SARS-CoV-2 nsp3. Biochemistry. PMID 32578982 DOI: 10.1021/Acs.Biochem.0C00309 |
0.764 |
|
| 2020 |
Ray A, Frick DN. Fluorescent probe displacement assays reveal unique nucleic acid binding properties of human nudix enzymes. Analytical Biochemistry. 595: 113622. PMID 32059949 DOI: 10.1016/J.Ab.2020.113622 |
0.402 |
|
| 2018 |
Corby MJ, Raicu V, Frick DN. New Techniques to Study Intracellular Receptors in Living Cells: Insights Into RIG-I-Like Receptor Signaling. Advances in Experimental Medicine and Biology. PMID 30471070 DOI: 10.1007/5584_2018_297 |
0.318 |
|
| 2018 |
Yerukhimovich MM, Marohnic CC, Frick DN. Role of the Conserved DECH-box Cysteine in Coupling Hepatitis C Virus Helicase-catalyzed ATP hydrolysis to RNA Unwinding. Biochemistry. PMID 30281972 DOI: 10.1021/Acs.Biochem.8B00796 |
0.546 |
|
| 2017 |
Corby MJ, Stoneman MR, Biener G, Paprocki JD, Kolli R, Raicu V, Frick DN. Quantitative Micro-Spectroscopic Imaging Reveals Viral and Cellular RNA Helicase Interactions in Live Cells. The Journal of Biological Chemistry. PMID 28483922 DOI: 10.1074/Jbc.M117.777045 |
0.469 |
|
| 2017 |
Bassetto M, Leyssen P, Neyts J, Yerukhimovich MM, Frick DN, Brancale A. Shape-based virtual screening, synthesis and evaluation of novel pyrrolone derivatives as antiviral agents against HCV. Bioorganic & Medicinal Chemistry Letters. PMID 28089348 DOI: 10.1016/J.Bmcl.2016.12.087 |
0.512 |
|
| 2016 |
Bassetto M, Ferla S, Leyssen P, Neyts J, Yerukhimovich MM, Frick DN, O'Donnell R, Brancale A. Novel symmetrical phenylenediamines as potential anti-hepatitis C virus agents. Antiviral Chemistry & Chemotherapy. PMID 27815332 DOI: 10.1177/2040206616676353 |
0.378 |
|
| 2016 |
Bassetto M, Leyssen P, Neyts J, Yerukhimovich MM, Frick DN, Courtney-Smith M, Brancale A. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase. European Journal of Medicinal Chemistry. 125: 1115-1131. PMID 27810598 DOI: 10.1016/J.Ejmech.2016.10.043 |
0.528 |
|
| 2016 |
Bassetto M, Leyssen P, Neyts J, Yerukhimovich MM, Frick DN, Brancale A. Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replication. European Journal of Medicinal Chemistry. 123: 31-47. PMID 27474921 DOI: 10.1016/J.Ejmech.2016.07.035 |
0.512 |
|
| 2016 |
Kaushik-Basu N, Ratmanova NK, Manvar D, Belov DS, Cevik O, Basu A, Yerukhimovich MM, Lukyanenko ER, Andreev IA, Belov GM, Manfroni G, Cecchetti V, Frick DN, Kurkin AV, Altieri A, et al. Bicyclic octahydrocyclohepta[b]pyrrol-4(1H)one derivatives as novel selective anti-hepatitis C virus agents. European Journal of Medicinal Chemistry. 122: 319-325. PMID 27376494 DOI: 10.1016/J.Ejmech.2016.06.041 |
0.43 |
|
| 2015 |
Provazzi PJ, Mukherjee S, Hanson AM, Nogueira ML, Carneiro BM, Frick DN, Rahal P. Analysis of the Enzymatic Activity of an NS3 Helicase Genotype 3a Variant Sequence Obtained from a Relapse Patient. Plos One. 10: e0144638. PMID 26658750 DOI: 10.1371/Journal.Pone.0144638 |
0.505 |
|
| 2015 |
Sweeney NL, Hanson AM, Mukherjee S, Ndjomou J, Geiss BJ, Steel JJ, Frankowski KJ, Li K, Schoenen FJ, Frick DN. Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase. Acs Infectious Diseases. 1: 140-148. PMID 26029739 DOI: 10.1021/Id5000458 |
0.55 |
|
| 2015 |
Ndjomou J, Corby MJ, Sweeney NL, Hanson AM, Aydin C, Ali A, Schiffer CA, Li K, Frankowski KJ, Schoenen FJ, Frick DN. Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy. Acs Chemical Biology. PMID 25961497 DOI: 10.1021/Acschembio.5B00101 |
0.529 |
|
| 2015 |
Andreev IA, Manvar D, Barreca ML, Belov DS, Basu A, Sweeney NL, Ratmanova NK, Lukyanenko ER, Manfroni G, Cecchetti V, Frick DN, Altieri A, Kaushik-Basu N, Kurkin AV. Discovery of the 2-phenyl-4,5,6,7-Tetrahydro-1H-indole as a novel anti-hepatitis C virus targeting scaffold. European Journal of Medicinal Chemistry. 96: 250-8. PMID 25890075 DOI: 10.1016/J.Ejmech.2015.04.022 |
0.512 |
|
| 2014 |
Mukherjee S, Weiner WS, Schroeder CE, Simpson DS, Hanson AM, Sweeney NL, Marvin RK, Ndjomou J, Kolli R, Isailovic D, Schoenen FJ, Frick DN. Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication. Acs Chemical Biology. 9: 2393-403. PMID 25126694 DOI: 10.1021/Cb500512Z |
0.572 |
|
| 2013 |
Aydin C, Mukherjee S, Hanson AM, Frick DN, Schiffer CA. The interdomain interface in bifunctional enzyme protein 3/4A (NS3/4A) regulates protease and helicase activities. Protein Science : a Publication of the Protein Society. 22: 1786-98. PMID 24123290 DOI: 10.1002/Pro.2378 |
0.449 |
|
| 2013 |
Shadrick WR, Mukherjee S, Hanson AM, Sweeney NL, Frick DN. Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP. Biochemistry. 52: 6151-9. PMID 23947785 DOI: 10.1021/Bi4006495 |
0.527 |
|
| 2013 |
Sweeney NL, Shadrick WR, Mukherjee S, Li K, Frankowski KJ, Schoenen FJ, Frick DN. Primuline derivatives that mimic RNA to stimulate hepatitis C virus NS3 helicase-catalyzed ATP hydrolysis. The Journal of Biological Chemistry. 288: 19949-57. PMID 23703611 DOI: 10.1074/Jbc.M113.463166 |
0.562 |
|
| 2013 |
Mannan MA, Shadrick WR, Biener G, Shin BS, Anshu A, Raicu V, Frick DN, Dey M. An ire1-phk1 chimera reveals a dispensable role of autokinase activity in endoplasmic reticulum stress response. Journal of Molecular Biology. 425: 2083-99. PMID 23541589 DOI: 10.1016/J.Jmb.2013.02.036 |
0.31 |
|
| 2013 |
Shadrick WR, Ndjomou J, Kolli R, Mukherjee S, Hanson AM, Frick DN. Discovering new medicines targeting helicases: challenges and recent progress. Journal of Biomolecular Screening. 18: 761-81. PMID 23536547 DOI: 10.1177/1087057113482586 |
0.424 |
|
| 2012 |
Ndjomou J, Kolli R, Mukherjee S, Shadrick WR, Hanson AM, Sweeney NL, Bartczak D, Li K, Frankowski KJ, Schoenen FJ, Frick DN. Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation. Antiviral Research. 96: 245-55. PMID 22940425 DOI: 10.1016/J.Antiviral.2012.08.006 |
0.581 |
|
| 2012 |
Mukherjee S, Hanson AM, Shadrick WR, Ndjomou J, Sweeney NL, Hernandez JJ, Bartczak D, Li K, Frankowski KJ, Heck JA, Arnold LA, Schoenen FJ, Frick DN. Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays. Nucleic Acids Research. 40: 8607-21. PMID 22740655 DOI: 10.1093/Nar/Gks623 |
0.548 |
|
| 2012 |
Hanson AM, Hernandez JJ, Shadrick WR, Frick DN. Identification and analysis of inhibitors targeting the hepatitis C virus NS3 helicase. Methods in Enzymology. 511: 463-83. PMID 22713333 DOI: 10.1016/B978-0-12-396546-2.00021-8 |
0.541 |
|
| 2012 |
Mastrangelo E, Pezzullo M, De Burghgraeve T, Kaptein S, Pastorino B, Dallmeier K, de Lamballerie X, Neyts J, Hanson AM, Frick DN, Bolognesi M, Milani M. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. The Journal of Antimicrobial Chemotherapy. 67: 1884-94. PMID 22535622 DOI: 10.1093/Jac/Dks147 |
0.32 |
|
| 2012 |
Li K, Frankowski KJ, Belon CA, Neuenswander B, Ndjomou J, Hanson AM, Shanahan MA, Schoenen FJ, Blagg BS, Aubé J, Frick DN. Optimization of potent hepatitis C virus NS3 helicase inhibitors isolated from the yellow dyes thioflavine S and primuline. Journal of Medicinal Chemistry. 55: 3319-30. PMID 22409723 DOI: 10.1021/Jm300021V |
0.796 |
|
| 2011 |
Peng LF, Schaefer EA, Maloof N, Skaff A, Berical A, Belon CA, Heck JA, Lin W, Frick DN, Allen TM, Miziorko HM, Schreiber SL, Chung RT. Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase. The Journal of Infectious Diseases. 204: 609-16. PMID 21791663 DOI: 10.1093/Infdis/Jir303 |
0.8 |
|
| 2011 |
Mousseau G, Kota S, Takahashi V, Frick DN, Strosberg AD. Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase. The Journal of General Virology. 92: 101-11. PMID 20881089 DOI: 10.1099/Vir.0.023325-0 |
0.523 |
|
| 2010 |
Lam AM, Murakami E, Espiritu C, Steuer HM, Niu C, Keilman M, Bao H, Zennou V, Bourne N, Julander JG, Morrey JD, Smee DF, Frick DN, Heck JA, Wang P, et al. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. Antimicrobial Agents and Chemotherapy. 54: 3187-96. PMID 20516278 DOI: 10.1128/Aac.00399-10 |
0.538 |
|
| 2010 |
Lemon SM, McKeating JA, Pietschmann T, Frick DN, Glenn JS, Tellinghuisen TL, Symons J, Furman PA. Development of novel therapies for hepatitis C. Antiviral Research. 86: 79-92. PMID 20417376 DOI: 10.1016/J.Antiviral.2010.02.003 |
0.495 |
|
| 2010 |
Meng X, Zhou Y, Lee EY, Lee MY, Frick DN. The p12 subunit of human polymerase delta modulates the rate and fidelity of DNA synthesis. Biochemistry. 49: 3545-54. PMID 20334433 DOI: 10.1021/Bi100042B |
0.326 |
|
| 2010 |
Frick DN, Ginzburg O, Lam AM. A method to simultaneously monitor hepatitis C virus NS3 helicase and protease activities. Methods in Molecular Biology (Clifton, N.J.). 587: 223-33. PMID 20225153 DOI: 10.1007/978-1-60327-355-8_16 |
0.527 |
|
| 2010 |
Belon CA, High YD, Lin TI, Pauwels F, Frick DN. Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor. Biochemistry. 49: 1822-32. PMID 20108979 DOI: 10.1021/Bi901974A |
0.806 |
|
| 2009 |
Belon CA, Frick DN. Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C. Future Virology. 4: 277-293. PMID 20161209 DOI: 10.2217/Fvl.09.7 |
0.796 |
|
| 2009 |
Belon CA, Frick DN. Fuel specificity of the hepatitis C virus NS3 helicase. Journal of Molecular Biology. 388: 851-64. PMID 19332076 DOI: 10.1016/J.Jmb.2009.03.059 |
0.805 |
|
| 2009 |
Heck JA, Meng X, Frick DN. Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymerase. Biochemical Pharmacology. 77: 1173-80. PMID 19174155 DOI: 10.1016/J.Bcp.2008.12.019 |
0.514 |
|
| 2009 |
Meng X, Zhou Y, Zhang S, Lee EY, Frick DN, Lee MY. DNA damage alters DNA polymerase delta to a form that exhibits increased discrimination against modified template bases and mismatched primers. Nucleic Acids Research. 37: 647-57. PMID 19074196 DOI: 10.1093/Nar/Gkn1000 |
0.342 |
|
| 2009 |
Frick D. New Methods to Identify and Analyze HCV Helicase Inhibitors Antiviral Research. 82: A19. DOI: 10.1016/J.Antiviral.2009.02.018 |
0.473 |
|
| 2009 |
Rypma RS, Lam AMI, Frick DN. Effect of substrate traps on hepatitis C virus NS3 helicase catalyzed DNA unwinding: Evidence for enzyme catalyzed strand exchange Bacterial Dna, Dna Polymerase and Dna Helicases. 389-407. |
0.488 |
|
| 2008 |
Belon CA, Frick DN. Monitoring helicase activity with molecular beacons. Biotechniques. 45: 433-40, 442. PMID 18855770 DOI: 10.2144/000112834 |
0.796 |
|
| 2008 |
Heck JA, Lam AM, Narayanan N, Frick DN. Effects of mutagenic and chain-terminating nucleotide analogs on enzymes isolated from hepatitis C virus strains of various genotypes. Antimicrobial Agents and Chemotherapy. 52: 1901-11. PMID 18391043 DOI: 10.1128/Aac.01496-07 |
0.539 |
|
| 2008 |
Neumann-Haefelin C, Frick DN, Wang JJ, Pybus OG, Salloum S, Narula GS, Eckart A, Biezynski A, Eiermann T, Klenerman P, Viazov S, Roggendorf M, Thimme R, Reiser M, Timm J. Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level. Journal of Virology. 82: 3438-51. PMID 18216107 DOI: 10.1128/Jvi.01700-07 |
0.459 |
|
| 2007 |
Frick DN. The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target. Current Issues in Molecular Biology. 9: 1-20. PMID 17263143 |
0.446 |
|
| 2007 |
Frick DN, Banik S, Rypma RS. Role of divalent metal cations in ATP hydrolysis catalyzed by the hepatitis C virus NS3 helicase: magnesium provides a bridge for ATP to fuel unwinding. Journal of Molecular Biology. 365: 1017-32. PMID 17084859 DOI: 10.1016/J.Jmb.2006.10.023 |
0.509 |
|
| 2006 |
Frick DN. Step-by-step progress toward understanding the hepatitis C virus RNA helicase. Hepatology (Baltimore, Md.). 43: 1392-5. PMID 16729317 DOI: 10.1002/Hep.21200 |
0.478 |
|
| 2006 |
Frick DN, Lam AM. Understanding helicases as a means of virus control. Current Pharmaceutical Design. 12: 1315-38. PMID 16611118 DOI: 10.2174/138161206776361147 |
0.444 |
|
| 2006 |
Lam AM, Frick DN. Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase. Journal of Virology. 80: 404-11. PMID 16352565 DOI: 10.1128/Jvi.80.1.404-411.2006 |
0.539 |
|
| 2004 |
Frick DN, Rypma RS, Lam AM, Frenz CM. Electrostatic analysis of the hepatitis C virus NS3 helicase reveals both active and allosteric site locations. Nucleic Acids Research. 32: 5519-28. PMID 15479787 DOI: 10.1093/Nar/Gkh891 |
0.51 |
|
| 2004 |
Lam AM, Rypma RS, Frick DN. Enhanced nucleic acid binding to ATP-bound hepatitis C virus NS3 helicase at low pH activates RNA unwinding. Nucleic Acids Research. 32: 4060-70. PMID 15289579 DOI: 10.1093/Nar/Gkh743 |
0.497 |
|
| 2004 |
Frick DN, Rypma RS, Lam AM, Gu B. The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently. The Journal of Biological Chemistry. 279: 1269-80. PMID 14585830 DOI: 10.1074/Jbc.M310630200 |
0.491 |
|
| 2004 |
Frick DN. The hepatitis C virus replicase: Insights into RNA-dependent RNA replication and prospects for rational drug design Current Organic Chemistry. 8: 223-241. DOI: 10.2174/1385272043485963 |
0.539 |
|
| 2003 |
Frick DN. Helicases as antiviral drug targets. Drug News & Perspectives. 16: 355-62. PMID 12973446 DOI: 10.1358/Dnp.2003.16.6.829307 |
0.536 |
|
| 2003 |
Lam AM, Keeney D, Frick DN. Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action. The Journal of Biological Chemistry. 278: 44514-24. PMID 12944414 DOI: 10.1074/Jbc.M306444200 |
0.513 |
|
| 2003 |
Lam AM, Keeney D, Eckert PQ, Frick DN. Hepatitis C virus NS3 ATPases/helicases from different genotypes exhibit variations in enzymatic properties. Journal of Virology. 77: 3950-61. PMID 12634355 DOI: 10.1128/Jvi.77.7.3950-3961.2003 |
0.465 |
|
| 2003 |
RYPMA R, LAM A, FRICK D. 1070 Effects of the protease domain of hepatitis C virus NS3 protein on its helicase activity Hepatology. 38: 671-671. DOI: 10.1016/S0270-9139(03)81108-4 |
0.431 |
|
| 2003 |
Frick DN, Lam AMI, Keeney D. 392 Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action Hepatology. 38: 349-349. DOI: 10.1016/S0270-9139(03)80435-4 |
0.432 |
|
| 2001 |
Frick DN, Richardson CC. DNA primases. Annual Review of Biochemistry. 70: 39-80. PMID 11395402 DOI: 10.1146/annurev.biochem.70.1.39 |
0.46 |
|
| 2001 |
Kato M, Frick DN, Lee J, Tabor S, Richardson CC, Ellenberger T. A complex of the bacteriophage T7 primase-helicase and DNA polymerase directs primer utilization. The Journal of Biological Chemistry. 276: 21809-20. PMID 11279245 DOI: 10.1074/Jbc.M101470200 |
0.506 |
|
| 2000 |
Tseng TY, Frick DN, Richardson CC. Characterization of a novel DNA primase from the Salmonella typhimurium bacteriophage SP6. Biochemistry. 39: 1643-54. PMID 10677213 DOI: 10.1021/Bi992155T |
0.497 |
|
| 1999 |
Frick DN, Kumar S, Richardson CC. Interaction of ribonucleoside triphosphates with the gene 4 primase of bacteriophage T7 Journal of Biological Chemistry. 274: 35899-35907. PMID 10585475 DOI: 10.1074/Jbc.274.50.35899 |
0.517 |
|
| 1999 |
Frick DN, Richardson CC. Interaction of bacteriophage T7 gene 4 primase with its template recognition site Journal of Biological Chemistry. 274: 35889-35898. PMID 10585474 DOI: 10.1074/Jbc.274.50.35889 |
0.524 |
|
| 1999 |
Dunn CA, O'Handley SF, Frick DN, Bessman MJ. Studies on the ADP-ribose pyrophosphatase subfamily of the nudix hydrolases and tentative identification of trgB, a gene associated with tellurite resistance. The Journal of Biological Chemistry. 274: 32318-24. PMID 10542272 DOI: 10.1074/Jbc.274.45.32318 |
0.576 |
|
| 1998 |
Frick DN, Baradaran K, Richardson CC. An N-terminal fragment of the gene 4 helicase/primase of bacteriophage T7 retains primase activity in the absence of helicase activity Proceedings of the National Academy of Sciences of the United States of America. 95: 7957-7962. PMID 9653122 DOI: 10.1073/Pnas.95.14.7957 |
0.493 |
|
| 1998 |
O'Handley SF, Frick DN, Dunn CA, Bessman MJ. Orf186 represents a new member of the Nudix hydrolases, active on adenosine(5')triphospho(5')adenosine, ADP-ribose, and NADH. The Journal of Biological Chemistry. 273: 3192-7. PMID 9452430 DOI: 10.1074/Jbc.273.6.3192 |
0.61 |
|
| 1997 |
Lin J, Abeygunawardana C, Frick DN, Bessman MJ, Mildvan AS. Solution structure of the quaternary MutT-M2+-AMPCPP-M2+ complex and mechanism of its pyrophosphohydrolase action. Biochemistry. 36: 1199-211. PMID 9063868 DOI: 10.1021/Bi962619C |
0.62 |
|
| 1996 |
Bessman MJ, Frick DN, O'Handley SF. The MutT proteins or 'Nudix' hydrolases, a family of versatile, widely distributed, 'housecleaning' enzymes Journal of Biological Chemistry. 271: 25059-25062. PMID 8810257 DOI: 10.1074/Jbc.271.41.25059 |
0.579 |
|
| 1996 |
O'Handley SF, Frick DN, Bullions LC, Mildvan AS, Bessman MJ. Escherichia coli orf17 codes for a nucleoside triphosphate pyrophosphohydrolase member of the MutT family of proteins. Cloning, purification, and characterization of the enzyme. The Journal of Biological Chemistry. 271: 24649-54. PMID 8798731 DOI: 10.1074/Jbc.271.40.24649 |
0.627 |
|
| 1996 |
Lin J, Abeygunawardana C, Frick DN, Bessman MJ, Mildvan AS. The role of Glu 57 in the mechanism of the Escherichia coli MutT enzyme by mutagenesis and heteronuclear NMR. Biochemistry. 35: 6715-26. PMID 8639622 DOI: 10.1021/Bi953071X |
0.602 |
|
| 1995 |
Frick DN, Bessman MJ. Cloning, purification, and properties of a novel NADH pyrophosphatase. Evidence for a nucleotide pyrophosphatase catalytic domain in MutT-like enzymes Journal of Biological Chemistry. 270: 1529-1534. PMID 7829480 DOI: 10.1074/Jbc.270.4.1529 |
0.606 |
|
| 1995 |
Frick DN, Weber DJ, Abeygunawardana C, Gittis AG, Bessman MJ, Mildvan AS. NMR studies of the conformations and location of nucleotides bound to the Escherichia coli MutT enzyme. Biochemistry. 34: 5577-86. PMID 7727419 DOI: 10.1021/Bi00016A032 |
0.619 |
|
| 1995 |
Frick DN, Townsend BD, Bessman MJ. A novel GDP-mannose mannosyl hydrolase shares homology with the MutT family of enzymes Journal of Biological Chemistry. 270: 24086-24091. PMID 7592609 DOI: 10.1074/Jbc.270.41.24086 |
0.616 |
|
| 1995 |
Abeygunawardana C, Weber DJ, Gittis AG, Frick DN, Lin J, Miller AF, Bessman MJ, Mildvan AS. Solution structure of the MutT enzyme, a nucleoside triphosphate pyrophosphohydrolase. Biochemistry. 34: 14997-5005. PMID 7578113 DOI: 10.1021/Bi00046A006 |
0.588 |
|
| 1994 |
Frick DN, Weber DJ, Gillespie JR, Bessman MJ, Mildvan AS. Dual divalent cation requirement of the MutT dGTPase. Kinetic and magnetic resonance studies of the metal and substrate complexes. The Journal of Biological Chemistry. 269: 1794-803. PMID 8294428 |
0.561 |
|
| 1993 |
Abeygunawardana C, Weber DJ, Frick DN, Bessman MJ, Mildvan AS. Sequence-specific assignments of the backbone 1H, 13C, and 15N resonances of the MutT enzyme by heteronuclear multidimensional NMR. Biochemistry. 32: 13071-80. PMID 8241161 DOI: 10.1021/Bi00211A017 |
0.602 |
|
| Show low-probability matches. |